{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:20:03Z","timestamp":1781306403406,"version":"3.54.1"},"reference-count":103,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K08 DK118120"],"award-info":[{"award-number":["K08 DK118120"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ackdjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1053\/j.ackd.2022.01.004","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T19:32:57Z","timestamp":1657308777000},"page":"86-102.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Monoclonal Gammopathy\u2013Related Kidney Diseases"],"prefix":"10.1053","volume":"29","author":[{"given":"Janina Paula T.","family":"Sy-Go","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra M.","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surya V.","family":"Seshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1053\/j.ackd.2022.01.004_bib1","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/leu.2010.60","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management","volume":"24","author":"Kyle","year":"2010","journal-title":"Leukemia"},{"issue":"1","key":"10.1053\/j.ackd.2022.01.004_bib2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41581-018-0077-4","article-title":"The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group","volume":"15","author":"Leung","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"10.1053\/j.ackd.2022.01.004_bib3","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41581-021-00405-7","article-title":"Kidney injury and disease in patients with haematological malignancies","volume":"17","author":"Bridoux","year":"2021","journal-title":"Nat Rev Nephrol"},{"issue":"20","key":"10.1053\/j.ackd.2022.01.004_bib4","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1056\/NEJMra1810907","article-title":"Monoclonal gammopathy of renal significance","volume":"384","author":"Leung","year":"2021","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1053\/j.ackd.2022.01.004_bib5","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1681\/ASN.2017121319","article-title":"The complexity and heterogeneity of monoclonal immunoglobulin-associated renal diseases","volume":"29","author":"Sethi","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"14","key":"10.1053\/j.ackd.2022.01.004_bib6","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1182\/blood-2018-04-839480","article-title":"Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications","volume":"132","author":"Fermand","year":"2018","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.ackd.2022.01.004_bib7","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ki.2014.408","article-title":"Diagnosis of monoclonal gammopathy of renal significance","volume":"87","author":"Bridoux","year":"2015","journal-title":"Kidney Int"},{"issue":"9","key":"10.1053\/j.ackd.2022.01.004_bib8","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.2215\/CJN.10491012","article-title":"Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases","volume":"8","author":"Said","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ackd.2022.01.004_bib9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.mayocp.2018.08.041","article-title":"Incidence of AL amyloidosis in Olmsted county, Minnesota, 1990 through 2015","volume":"94","author":"Kyle","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"15","key":"10.1053\/j.ackd.2022.01.004_bib10","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1182\/blood-2014-04-570010","article-title":"A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis","volume":"124","author":"Palladini","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.ackd.2022.01.004_bib11","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/ndt\/gfr381","article-title":"Clinical features of patients with immunoglobulin light chain amyloidosis (AL) with vascular-limited deposition in the kidney","volume":"27","author":"Eirin","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1053\/j.ackd.2022.01.004_bib12","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.2215\/CJN.02980316","article-title":"Paraprotein-related kidney disease: glomerular diseases associated with paraproteinemias","volume":"11","author":"Motwani","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"10.1053\/j.ackd.2022.01.004_bib13","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/ajh.25819","article-title":"Immunoglobulin light chain amyloidosis: 2020 update on diagnosis, prognosis, and treatment","volume":"95","author":"Gertz","year":"2020","journal-title":"Am J Hematol"},{"issue":"9","key":"10.1053\/j.ackd.2022.01.004_bib14","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/ndt\/gfy291","article-title":"AL amyloidosis: advances in diagnostics and treatment","volume":"34","author":"Rysava","year":"2019","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1053\/j.ackd.2022.01.004_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.clml.2019.02.009","article-title":"Autologous hematopoietic cell transplantation versus chemotherapy alone for immunoglobulin light chain amyloidosis: a retrospective study","volume":"19","author":"Miyazaki","year":"2019","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"7","key":"10.1053\/j.ackd.2022.01.004_bib16","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1182\/blood-2017-01-763599","article-title":"Daratumumab yields rapid and deep hematologic responses in patients with heavily pretreated AL amyloidosis","volume":"130","author":"Kaufman","year":"2017","journal-title":"Blood"},{"key":"10.1053\/j.ackd.2022.01.004_bib17","doi-asserted-by":"crossref","first-page":"100361","DOI":"10.1016\/j.eclinm.2020.100361","article-title":"Adjuvant doxycycline to enhance anti-amyloid effects: results from the dual phase 2 trial","volume":"23","author":"D'Souza","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"11","key":"10.1053\/j.ackd.2022.01.004_bib18","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/ajh.25940","article-title":"Refining amyloid complete hematological response: quantitative serum free light chains superior to ratio","volume":"95","author":"Muchtar","year":"2020","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1053\/j.ackd.2022.01.004_bib19","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/ndt\/gfaa293","article-title":"Renal transplant outcomes in amyloidosis","volume":"36","author":"Law","year":"2021","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1053\/j.ackd.2022.01.004_bib20","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.kint.2020.06.036","article-title":"A study from the Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosis","volume":"99","author":"Heybeli","year":"2021","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ackd.2022.01.004_bib21","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1093\/ndt\/gfr067","article-title":"Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation","volume":"26","author":"Herrmann","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1053\/j.ackd.2022.01.004_bib22","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2215\/CJN.08300910","article-title":"Fibrillary glomerulonephritis: a report of 66 cases from a single institution","volume":"6","author":"Nasr","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ackd.2022.01.004_bib23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ekir.2017.07.017","article-title":"DNAJB9 is a specific immunohistochemical marker for fibrillary glomerulonephritis","volume":"3","author":"Nasr","year":"2018","journal-title":"Kidney Int Rep"},{"issue":"3","key":"10.1053\/j.ackd.2022.01.004_bib24","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000455390","article-title":"Clinical features and outcomes of a racially diverse population with fibrillary glomerulonephritis","volume":"45","author":"Payan Schober","year":"2017","journal-title":"Am J Nephrol"},{"issue":"12","key":"10.1053\/j.ackd.2022.01.004_bib25","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.2215\/CJN.03870319","article-title":"Fibrillary glomerulonephritis: clinicopathologic features and atypical cases from a Multi-Institutional cohort","volume":"14","author":"Andeen","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"10.1053\/j.ackd.2022.01.004_bib26","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.ekir.2019.04.013","article-title":"Fibrillary glomerulonephritis: an update","volume":"4","author":"Rosenstock","year":"2019","journal-title":"Kidney Int Rep"},{"issue":"3","key":"10.1053\/j.ackd.2022.01.004_bib27","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.kint.2019.03.021","article-title":"New developments in the diagnosis of fibrillary glomerulonephritis","volume":"96","author":"Nasr","year":"2019","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ackd.2022.01.004_bib28","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1053\/j.ajkd.2013.03.031","article-title":"Long-term kidney disease outcomes in fibrillary glomerulonephritis: a case series of 27 patients","volume":"62","author":"Javaugue","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1053\/j.ackd.2022.01.004_bib29","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1093\/ndt\/gfu189","article-title":"Rituximab treatment for fibrillary glomerulonephritis","volume":"29","author":"Hogan","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1053\/j.ackd.2022.01.004_bib30","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/ndt\/gfaa065","article-title":"Treatment of fibrillary glomerulonephritis with rituximab: a 12-month pilot study","volume":"36","author":"Erickson","year":"2021","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"10.1053\/j.ackd.2022.01.004_bib31","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1093\/ndt\/gfs348","article-title":"Immunotactoid glomerulopathy: clinicopathologic and proteomic study","volume":"27","author":"Nasr","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1053\/j.ackd.2022.01.004_bib32","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.kint.2020.07.037","article-title":"Immunotactoid glomerulopathy is a rare entity with monoclonal and polyclonal variants","volume":"99","author":"Nasr","year":"2021","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ackd.2022.01.004_bib33","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2215\/CJN.00560117","article-title":"Dysproteinemias and glomerular disease","volume":"13","author":"Leung","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ackd.2022.01.004_bib34","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3109\/01913123.2015.1017070","article-title":"Immunotactoid glomerulopathy and cryoglobulinemic nephropathy: two entities with many similarities. A unified conceptual approach","volume":"39","author":"Herrera","year":"2015","journal-title":"Ultrastruct Pathol"},{"issue":"Suppl 1","key":"10.1053\/j.ackd.2022.01.004_bib35","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.nephro.2016.01.010","volume":"12","author":"Zaidan","year":"2016","journal-title":"Nephrol Ther"},{"issue":"5","key":"10.1053\/j.ackd.2022.01.004_bib36","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/bjh.13196","article-title":"Clinico-biological characteristics and treatment of type I monoclonal cryoglobulinaemia: a study of 64 cases","volume":"168","author":"Harel","year":"2015","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1053\/j.ackd.2022.01.004_bib37","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/ajh.24745","article-title":"Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia","volume":"92","author":"Sidana","year":"2017","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1053\/j.ackd.2022.01.004_bib38","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.kint.2020.06.039","article-title":"Results of a nation-wide cohort study suggest favorable long-term outcomes of clone-targeted chemotherapy in immunotactoid glomerulopathy","volume":"99","author":"Javaugue","year":"2021","journal-title":"Kidney Int"},{"issue":"9","key":"10.1053\/j.ackd.2022.01.004_bib39","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1016\/j.transproceed.2009.03.100","article-title":"A case of recurrent immunotactoid glomerulopathy in an allograft treated with rituximab","volume":"41","author":"Sathyan","year":"2009","journal-title":"Transplant Proc"},{"issue":"4","key":"10.1053\/j.ackd.2022.01.004_bib40","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ekir.2020.01.011","article-title":"The role of kidney transplantation in monoclonal Ig deposition disease","volume":"5","author":"Angel-Korman","year":"2020","journal-title":"Kidney Int Rep"},{"issue":"9","key":"10.1053\/j.ackd.2022.01.004_bib41","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1681\/ASN.2009010110","article-title":"Proliferative glomerulonephritis with monoclonal IgG deposits","volume":"20","author":"Nasr","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ackd.2022.01.004_bib42","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/ajh.23608","article-title":"Long-term outcome of monoclonal (type 1) cryoglobulinemia","volume":"89","author":"Neel","year":"2014","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1053\/j.ackd.2022.01.004_bib43","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2215\/CJN.08640811","article-title":"Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution","volume":"7","author":"Nasr","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1053\/j.ackd.2022.01.004_bib44","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/ajh.24528","article-title":"Outcomes of patients with renal monoclonal immunoglobulin deposition disease","volume":"91","author":"Kourelis","year":"2016","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1053\/j.ackd.2022.01.004_bib45","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/ajh.24756","article-title":"Clinical characteristics and prognostic factors in multiple myeloma patients with light chain deposition disease","volume":"92","author":"Mohan","year":"2017","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1053\/j.ackd.2022.01.004_bib46","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1182\/blood-2018-09-872028","article-title":"Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study","volume":"133","author":"Joly","year":"2019","journal-title":"Blood"},{"issue":"7","key":"10.1053\/j.ackd.2022.01.004_bib47","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1182\/bloodadvances.2020001553","article-title":"Daratumumab in light chain deposition disease: rapid and profound hematologic response preserves kidney function","volume":"4","author":"Milani","year":"2020","journal-title":"Blood Adv"},{"issue":"5","key":"10.1053\/j.ackd.2022.01.004_bib48","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.mayocp.2015.01.024","article-title":"Hematologic characteristics of proliferative glomerulonephritides with nonorganized monoclonal immunoglobulin deposits","volume":"90","author":"Bhutani","year":"2015","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1053\/j.ackd.2022.01.004_bib49","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.kint.2018.02.020","article-title":"A clone-directed approach may improve diagnosis and treatment of proliferative glomerulonephritis with monoclonal immunoglobulin deposits","volume":"94","author":"Gumber","year":"2018","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ackd.2022.01.004_bib50","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.kint.2019.10.025","article-title":"Light chain only variant of proliferative glomerulonephritis with monoclonal immunoglobulin deposits is associated with a high detection rate of the pathogenic plasma cell clone","volume":"97","author":"Nasr","year":"2020","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.ackd.2022.01.004_bib51","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/ndt\/gfz176","article-title":"Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: a nephrologist perspective","volume":"36","author":"Bridoux","year":"2021","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1053\/j.ackd.2022.01.004_bib52","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1053\/j.ajkd.2005.10.023","article-title":"A proliferative glomerulonephritis secondary to a monoclonal IgA","volume":"47","author":"Soares","year":"2006","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1053\/j.ackd.2022.01.004_bib53","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1182\/blood-2016-08-737163","article-title":"Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy-associated C3 glomerulopathy","volume":"129","author":"Chauvet","year":"2017","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.ackd.2022.01.004_bib54","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1681\/ASN.2020101541","article-title":"Safety and efficacy of daratumumab in patients with proliferative GN with monoclonal immunoglobulin deposits","volume":"32","author":"Zand","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ackd.2022.01.004_bib55","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5414\/CN108339","article-title":"Recurrence of monoclonal IgA lambda glomerulonephritis in kidney allograft associated with multiple myeloma","volume":"84","author":"Herrmann","year":"2015","journal-title":"Clin Nephrol"},{"issue":"1","key":"10.1053\/j.ackd.2022.01.004_bib56","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.kint.2018.01.028","article-title":"Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits is associated with high rate of early recurrence in the allograft","volume":"94","author":"Said","year":"2018","journal-title":"Kidney Int"},{"issue":"7","key":"10.1053\/j.ackd.2022.01.004_bib57","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1097\/TP.0000000000002577","article-title":"Recurrent proliferative glomerulonephritis with monoclonal immunoglobulin deposits in kidney allografts treated with anti-CD20 antibodies","volume":"103","author":"Buxeda","year":"2019","journal-title":"Transplantation"},{"issue":"3","key":"10.1053\/j.ackd.2022.01.004_bib58","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41581-018-0107-2","article-title":"C3 glomerulopathy - understanding a rare complement-driven renal disease","volume":"15","author":"Smith","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"10.1053\/j.ackd.2022.01.004_bib59","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1053\/j.ackd.2019.12.003","article-title":"C3 glomerulopathy: pathogenesis and treatment","volume":"27","author":"Ahmad","year":"2020","journal-title":"Adv Chronic Kidney Dis"},{"issue":"1","key":"10.1053\/j.ackd.2022.01.004_bib60","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.kint.2018.01.037","article-title":"C3 glomerulopathy associated with monoclonal Ig is a distinct subtype","volume":"94","author":"Ravindran","year":"2018","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ackd.2022.01.004_bib61","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1053\/j.ajkd.2010.06.021","article-title":"Dense deposit disease associated with monoclonal gammopathy of undetermined significance","volume":"56","author":"Sethi","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1053\/j.ackd.2022.01.004_bib62","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1053\/j.ajkd.2013.02.370","article-title":"C3 glomerulonephritis associated with monoclonal gammopathy: a case series","volume":"62","author":"Zand","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ackd.2022.01.004_bib63","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.xkme.2019.01.006","article-title":"Crystalglobulin-induced nephropathy and keratopathy","volume":"1","author":"D'Costa","year":"2019","journal-title":"Kidney Med"},{"issue":"8","key":"10.1053\/j.ackd.2022.01.004_bib64","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.ekir.2019.04.020","article-title":"Crystalglobulin-induced nephropathy: unusual presentation in a patient with seronegative rheumatoid arthritis and leukocytoclastic vasculitis","volume":"4","author":"Vanga","year":"2019","journal-title":"Kidney Int Rep"},{"issue":"6","key":"10.1053\/j.ackd.2022.01.004_bib65","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1111\/ajt.16536","article-title":"Crystalglobulinemia causing cutaneous vasculopathy and acute nephropathy in a kidney transplant patient","volume":"21","author":"Wilson","year":"2021","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1053\/j.ackd.2022.01.004_bib66","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.kint.2016.09.045","article-title":"Thrombotic microangiopathy associated with monoclonal gammopathy","volume":"91","author":"Ravindran","year":"2017","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ackd.2022.01.004_bib67","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1053\/j.ajkd.2015.08.004","article-title":"AJKD Atlas of renal pathology: glomerulonephritis with dominant C3","volume":"66","author":"Lusco","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.ackd.2022.01.004_bib68","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1053\/j.ajkd.2015.03.035","article-title":"Kidney diseases associated with monoclonal immunoglobulin M-secreting B-cell lymphoproliferative disorders: a case series of 35 patients","volume":"66","author":"Chauvet","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.ackd.2022.01.004_bib69","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1681\/ASN.2013070715","article-title":"Clinical findings, pathology, and outcomes of C3GN after kidney transplantation","volume":"25","author":"Zand","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ackd.2022.01.004_bib70","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1053\/j.ajkd.2018.09.002","article-title":"Kidney transplantation in C3 glomerulopathy: a case series","volume":"73","author":"Regunathan-Shenk","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ackd.2022.01.004_bib71","first-page":"74","article-title":"A case of bilateral renal arterial thrombosis associated with cryocrystalglobulinaemia","volume":"3","author":"Leung","year":"2010","journal-title":"NDT Plus"},{"issue":"3","key":"10.1053\/j.ackd.2022.01.004_bib72","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1681\/ASN.2014050509","article-title":"Crystalglobulin-induced nephropathy","volume":"26","author":"Gupta","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1053\/j.ackd.2022.01.004_bib73","doi-asserted-by":"crossref","first-page":"E250","DOI":"10.1002\/ajh.25569","article-title":"Monoclonal gammopathy-associated thrombotic microangiopathy","volume":"94","author":"Yui","year":"2019","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1053\/j.ackd.2022.01.004_bib74","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ki.2013.548","article-title":"Membranous-like glomerulopathy with masked IgG kappa deposits","volume":"86","author":"Larsen","year":"2014","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ackd.2022.01.004_bib75","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ekir.2016.08.012","article-title":"Clinicopathologic features of membranous-like glomerulopathy with masked IgG kappa deposits","volume":"1","author":"Larsen","year":"2016","journal-title":"Kidney Int Rep"},{"issue":"3","key":"10.1053\/j.ackd.2022.01.004_bib76","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.kint.2019.10.026","article-title":"Serum amyloid P deposition is a sensitive and specific feature of membranous-like glomerulopathy with masked IgG kappa deposits","volume":"97","author":"Larsen","year":"2020","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ackd.2022.01.004_bib77","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000442511","article-title":"Current trends of renal impairment in multiple myeloma","volume":"1","author":"Yadav","year":"2016","journal-title":"Kidney Dis (Basel)"},{"issue":"6","key":"10.1053\/j.ackd.2022.01.004_bib78","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1053\/j.ajkd.2011.12.028","article-title":"Clinicopathologic correlations in multiple myeloma: a case series of 190 patients with kidney biopsies","volume":"59","author":"Nasr","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"10.1053\/j.ackd.2022.01.004_bib79","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1053\/j.ackd.2022.01.004_bib80","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.2215\/CJN.12231212","article-title":"Kidney disease and multiple myeloma","volume":"8","author":"Heher","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1053\/j.ackd.2022.01.004_bib81","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.2215\/CJN.01640216","article-title":"Paraprotein-related kidney disease: evaluation and treatment of myeloma cast nephropathy","volume":"11","author":"Finkel","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ackd.2022.01.004_bib82","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.kint.2019.01.027","article-title":"Clinicopathological spectrum of renal parenchymal involvement in B-cell lymphoproliferative disorders","volume":"96","author":"Javaugue","year":"2019","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ackd.2022.01.004_bib83","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41408-020-0295-4","article-title":"Serum free light chain level at diagnosis in myeloma cast nephropathy-a multicentre study","volume":"10","author":"Yadav","year":"2020","journal-title":"Blood Cancer J"},{"issue":"21","key":"10.1053\/j.ackd.2022.01.004_bib84","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1182\/blood.2019003807","article-title":"Clinicopathologic predictors of renal outcomes in light chain cast nephropathy: a multicenter retrospective study","volume":"135","author":"Royal","year":"2020","journal-title":"Blood"},{"issue":"12","key":"10.1053\/j.ackd.2022.01.004_bib85","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2215\/CJN.11161111","article-title":"Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseases","volume":"7","author":"Leung","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ackd.2022.01.004_bib86","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1053\/j.ajkd.2016.01.002","article-title":"AJKD atlas of renal pathology: light chain cast nephropathy","volume":"67","author":"Lusco","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.ackd.2022.01.004_bib87","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1681\/ASN.2010080857","article-title":"Early reduction of serum-free light chains associates with renal recovery in myeloma kidney","volume":"22","author":"Hutchison","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"21","key":"10.1053\/j.ackd.2022.01.004_bib88","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1001\/jama.2017.17924","article-title":"Effect of high-cutoff hemodialysis vs conventional hemodialysis on hemodialysis independence among patients with myeloma cast nephropathy: a randomized clinical trial","volume":"318","author":"Bridoux","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"10.1053\/j.ackd.2022.01.004_bib89","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00005792-200005000-00002","article-title":"Adult Fanconi syndrome secondary to light chain gammopathy. Clinicopathologic heterogeneity and unusual features in 11 patients","volume":"79","author":"Messiaen","year":"2000","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1053\/j.ackd.2022.01.004_bib90","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/ajh.25791","article-title":"Multiple myeloma: 2020 update on diagnosis, risk-stratification and management","volume":"95","author":"Rajkumar","year":"2020","journal-title":"Am J Hematol"},{"issue":"23","key":"10.1053\/j.ackd.2022.01.004_bib91","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1200\/JCO.20.00298","article-title":"Randomized trial comparing double versus triple bortezomib-based regimen in patients with multiple myeloma and acute kidney injury due to cast nephropathy","volume":"38","author":"Bridoux","year":"2020","journal-title":"J Clin Oncol"},{"issue":"1-2","key":"10.1053\/j.ackd.2022.01.004_bib92","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/2399369320905604","article-title":"Kidney transplant in multiple myeloma, the challenges, and potentials","volume":"4","author":"Leung","year":"2020","journal-title":"J Onco-Nephrology"},{"issue":"11","key":"10.1053\/j.ackd.2022.01.004_bib93","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1038\/modpathol.2011.104","article-title":"The morphologic spectrum and clinical significance of light chain proximal tubulopathy with and without crystal formation","volume":"24","author":"Larsen","year":"2011","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1053\/j.ackd.2022.01.004_bib94","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1681\/ASN.2015020185","article-title":"Light chain proximal tubulopathy: clinical and pathologic characteristics in the modern treatment era","volume":"27","author":"Stokes","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ackd.2022.01.004_bib95","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/leu.2016.195","article-title":"Current anti-myeloma therapies in renal manifestations of monoclonal light chain-associated Fanconi syndrome: a retrospective series of 49 patients","volume":"31","author":"Vignon","year":"2017","journal-title":"Leukemia"},{"issue":"5","key":"10.1053\/j.ackd.2022.01.004_bib96","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.clml.2013.04.008","article-title":"Acquired Fanconi syndrome secondary to monoclonal gammopathies: a case series from a single center","volume":"13","author":"Magnano","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"2","key":"10.1053\/j.ackd.2022.01.004_bib97","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1053\/j.ajkd.2015.12.006","article-title":"AJKD atlas of renal pathology: light chain proximal tubulopathy","volume":"67","author":"Fogo","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"22","key":"10.1053\/j.ackd.2022.01.004_bib98","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1182\/blood-2013-05-495929","article-title":"How I treat monoclonal gammopathy of renal significance (MGRS)","volume":"122","author":"Fermand","year":"2013","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.ackd.2022.01.004_bib99","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1053\/j.ajkd.2016.04.021","article-title":"Recurrent light chain proximal tubulopathy in a kidney allograft","volume":"68","author":"Angioi","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1053\/j.ackd.2022.01.004_bib100","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1093\/ndt\/gfq129","article-title":"Crystal-storing histiocytosis with renal Fanconi syndrome: pathological and molecular characteristics compared with classical myeloma-associated Fanconi syndrome","volume":"25","author":"El Hamel","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"10.1053\/j.ackd.2022.01.004_bib101","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S0344-0338(96)80037-9","article-title":"Gammopathy-related crystal-storing histiocytosis, pseudo- and pseudo-pseudo-Gaucher cells. Critical commentary and mini-review","volume":"192","author":"Schaefer","year":"1996","journal-title":"Pathol Res Pract"},{"issue":"2","key":"10.1053\/j.ackd.2022.01.004_bib102","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.kint.2015.12.012","article-title":"Crystal-storing histiocytosis","volume":"89","author":"Shah","year":"2016","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2022.01.004_bib103","doi-asserted-by":"crossref","first-page":"151403","DOI":"10.1016\/j.anndiagpath.2019.151403","article-title":"Renal crystal-storing histiocytosis involving glomeruli - a comprehensive clinicopathologic analysis","volume":"43","author":"Gupta","year":"2019","journal-title":"Ann Diagn Pathol"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559522000027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559522000027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:05:14Z","timestamp":1761548714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559522000027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":103,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1548559522000027"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2022.01.004","relation":{},"ISSN":["1548-5595"],"issn-type":[{"value":"1548-5595","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monoclonal Gammopathy\u2013Related Kidney Diseases","name":"articletitle","label":"Article Title"},{"value":"Advances in Chronic Kidney Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ackd.2022.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the National Kidney Foundation, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}